IDiyas

For the Inventor, By the Inventor

Durban, South Africa

Rashmi Venugopala

USPTO Granted Patents = 11

Average Co-Inventor Count = 5.5

ph-index = 1


Location History:

  • KwaZulu-Natal, ZA (2024)
  • Durban, ZA (2024)

Company Filing History:

goldMedal11 out of 3,201 
 
King Fahd University of Petroleum and Minerals
 patents

Years Active: 2024-2025

Loading Chart...
11 patents (USPTO):
1. 12215082 - (e)-1-(2-(4-substitutedphenyl)-2-oxoethyl)-4-((hydroxyimino)methyl)pyridinium bromides as antitubercular agents (2025-02-04),
2. 12194029 - Ethyl-1-(substitutedbenzoyl)-5-methylpyrrolo[1,2-a]quinoline-3-carboxylates as anticancer agents (2025-01-14),
3. 12172973 - (E)-2-(3-Cyano-4-isobutoxyphenyl)-N'-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agents (2024-12-24),
4. 12145936 - 7-Imino-5-(1H-indol-3-yl)-1,3-substituted-7,8-dihdropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione as anti-inflammatory agents (2024-11-19),
5. 11998532 - Substituted 1,3,4-oxadiazole derivatives as anti-tubercular agents (2024-06-04),
6. 11981643 - Oxoimidazolidine derivatives as anti-tubercular agents (2024-05-14),
7. 11976076 - Substituted 7,8-dihydropyrimido[4,5-d]pyrimidines as anti-tubercular agents (2024-05-07),
8. 11976066 - Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents (2024-05-07),
9. 11970470 - {5-chloro-2-(2-(3-(substitutedphenyl)-1,2,4-oxadiazol-5-yl)ethyl)phenyl}(phenyl)methanones as larvicidal agents (2024-04-30),
10. 11926602 - 4-amino-5-(4-fluoro-3-phenoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives as antifungal agents (2024-03-12),
11. 11905279 - Benzylidene derivatives of fenobam as anti-inflammatory agents (2024-02-20),

Title: Rashmi Venugopala: Innovator in Antitubercular and Anticancer Research

Introduction

Rashmi Venugopala is a prominent inventor based in Durban, South Africa. She has made significant contributions to the fields of medicine and pharmacology, particularly in the development of compounds for treating tuberculosis and cancer. With a total of 11 patents to her name, Rashmi is recognized for her innovative approaches to addressing critical health challenges.

Latest Patents

Rashmi's latest patents include groundbreaking work on (E)-1-(2-(4-substitutedphenyl)-2-oxoethyl)-4-((hydroxyimino)methyl)pyridinium bromides, which serve as antitubercular agents. These compounds are specifically designed for treating tuberculosis, showcasing her commitment to combating infectious diseases. Additionally, she has developed ethyl-1-(substitutedbenzoyl)-5-methylpyrrolo[1,2-a]quinoline-3-carboxylates as anticancer agents. This innovative method involves administering these compounds to patients in need of cancer treatment.

Career Highlights

Rashmi is currently affiliated with King Fahd University of Petroleum and Minerals, where she continues her research and development efforts. Her work has not only advanced scientific knowledge but has also contributed to potential therapeutic solutions for patients suffering from serious health conditions.

Collaborations

Rashmi collaborates with esteemed colleagues, including Katharigatta N Venugopala and Pran Kishore Deb. These partnerships enhance her research capabilities and foster a collaborative environment for innovation.

Conclusion

Rashmi Venugopala stands out as a dedicated inventor whose work in antitubercular and anticancer research has the potential to make a significant impact on global health. Her innovative spirit and commitment to scientific advancement continue to inspire others in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…